Arterial hypertension is the most prevalent modifiable risk factor associated with
cardiovascular morbidity and mortality. Although antihypertensive drugs are widely …

Hypertension continues to be a major contributor to global morbidity and mortality, fuelled by
an abundance of patients with uncontrolled blood pressure despite the multitude of …

Abstract Introduction Ventricular arrhythmias (VAs) in patients with chronic heart failure
(CHF) are sometimes refractory to antiarrhythmic drugs and cardiac ablation. This study …

Hypertension management poses a major challenge to clinicians globally once non-drug
(lifestyle) measures have failed to control blood pressure (BP). Although drug treatment …

Background: Renal denervation (RDN) is a catheter-based intervention to treat patients with
resistant hypertension. The biological effects of RDN are not fully understood, and …

Background This article summarizes the emerging field of hypertension over the last
decades. It covers paradigm shifts on hypertension from an undefined cardiovascular …

Improved and durable control of hypertension is a global priority for healthcare providers
and policymakers. There are several lifestyle measures that are proven to result in improved …

Abstract Background/Introduction The efficacy of catheter-based renal sympathetic
denervation (RDN) in terms of blood pressure (BP) reduction has been questioned, while …

Patients with treatment resistant hypertension (TRH) are known to have elevated sodium
(Na) content in muscle and skin. Renal denervation (RDN) emerged as an adjacent …

Objectives Renal denervation (RDN) has been introduced for reducing blood pressure (BP)
in treatment-resistant hypertension (TRH). The precise mechanism how RDN exerts its BP …